184 related articles for article (PubMed ID: 28684122)
1. Potent antiobesity effect of a short-length peptide YY-analogue continuously administered in mice.
Nishizawa N; Niida A; Adachi Y; Masuda Y; Kumano S; Yokoyama K; Asakawa T; Hirabayashi H; Amano N; Takekawa S; Ohtaki T; Asami T
Bioorg Med Chem Lett; 2017 Aug; 27(16):3829-3832. PubMed ID: 28684122
[TBL] [Abstract][Full Text] [Related]
2. Highly potent antiobesity effect of a short-length peptide YY analog in mice.
Nishizawa N; Niida A; Adachi Y; Kanematsu-Yamaki Y; Masuda Y; Kumano S; Yokoyama K; Noguchi Y; Asakawa T; Hirabayashi H; Amano N; Takekawa S; Ohtaki T; Asami T
Bioorg Med Chem; 2017 Oct; 25(20):5718-5725. PubMed ID: 28917449
[TBL] [Abstract][Full Text] [Related]
3. Antiobesity and emetic effects of a short-length peptide YY analog and its PEGylated and alkylated derivatives.
Niida A; Kanematsu-Yamaki Y; Asakawa T; Ishimura Y; Fujita H; Matsumiya K; Nishizawa N; Adachi Y; Mochida T; Tsuchimori K; Yoneyama-Hirozane M; Sakamoto J; Hirabayashi H; Fukui H; Takekawa S; Asami T
Bioorg Med Chem; 2018 Feb; 26(3):566-572. PubMed ID: 29279243
[TBL] [Abstract][Full Text] [Related]
4. Antiobesity Effect of a Short-Length Peptide YY Analogue after Continuous Administration in Mice.
Nishizawa N; Niida A; Masuda Y; Kumano S; Yokoyama K; Hirabayashi H; Amano N; Ohtaki T; Asami T
ACS Med Chem Lett; 2017 Jun; 8(6):628-631. PubMed ID: 28626523
[TBL] [Abstract][Full Text] [Related]
5. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
6. A Short-Length Peptide YY Analogue with Anorectic Effect in Mice.
Nishizawa N; Niida A; Masuda Y; Kumano S; Yokoyama K; Hirabayashi H; Amano N; Ohtaki T; Asami T
ACS Omega; 2017 May; 2(5):2200-2207. PubMed ID: 30023658
[TBL] [Abstract][Full Text] [Related]
7. Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.
Lumb KJ; DeCarr LB; Milardo LF; Mays MR; Buckholz TM; Fisk SE; Pellegrino CM; Ortiz AA; Mahle CD
J Med Chem; 2007 May; 50(9):2264-8. PubMed ID: 17425299
[TBL] [Abstract][Full Text] [Related]
8. Half-Life Extending Modifications of Peptide YY
Bech EM; Kaiser A; Bellmann-Sickert K; Nielsen SS; Sørensen KK; Elster L; Hatzakis N; Pedersen SL; Beck-Sickinger AG; Jensen KJ
Mol Pharm; 2019 Aug; 16(8):3665-3677. PubMed ID: 31310716
[TBL] [Abstract][Full Text] [Related]
9. Peptide architecture: adding an alpha-helix to the PYY lysine side chain provides nanomolar binding and body-weight-lowering effects.
Pedersen SL; Sasikumar PG; Vrang N; Jensen KJ
ChemMedChem; 2010 Apr; 5(4):545-51. PubMed ID: 20183851
[TBL] [Abstract][Full Text] [Related]
10. Gut hormone PYY(3-36) physiologically inhibits food intake.
Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR
Nature; 2002 Aug; 418(6898):650-4. PubMed ID: 12167864
[TBL] [Abstract][Full Text] [Related]
11. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
Ortiz AA; Milardo LF; DeCarr LB; Buckholz TM; Mays MR; Claus TH; Livingston JN; Mahle CD; Lumb KJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):692-700. PubMed ID: 17671099
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
13. The gut hormone peptide YY regulates appetite.
Batterham RL; Bloom SR
Ann N Y Acad Sci; 2003 Jun; 994():162-8. PubMed ID: 12851312
[TBL] [Abstract][Full Text] [Related]
14. PYY3-36 as an anti-obesity drug target.
Boggiano MM; Chandler PC; Oswald KD; Rodgers RJ; Blundell JE; Ishii Y; Beattie AH; Holch P; Allison DB; Schindler M; Arndt K; Rudolf K; Mark M; Schoelch C; Joost HG; Klaus S; Thöne-Reineke C; Benoit SC; Seeley RJ; Beck-Sickinger AG; Koglin N; Raun K; Madsen K; Wulff BS; Stidsen CE; Birringer M; Kreuzer OJ; Deng XY; Whitcomb DC; Halem H; Taylor J; Dong J; Datta R; Culler M; Ortmann S; Castañeda TR; Tschöp M
Obes Rev; 2005 Nov; 6(4):307-22. PubMed ID: 16246216
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
[TBL] [Abstract][Full Text] [Related]
16. Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice.
Pedersen SL; Sasikumar PG; Chelur S; Holst B; Artmann A; Jensen KJ; Vrang N
J Pept Sci; 2010 Nov; 16(11):664-73. PubMed ID: 20853314
[TBL] [Abstract][Full Text] [Related]
17. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
18. Vitamin B12 conjugation of peptide-YY(3-36) decreases food intake compared to native peptide-YY(3-36) upon subcutaneous administration in male rats.
Henry KE; Elfers CT; Burke RM; Chepurny OG; Holz GG; Blevins JE; Roth CL; Doyle RP
Endocrinology; 2015 May; 156(5):1739-49. PubMed ID: 25658456
[TBL] [Abstract][Full Text] [Related]
19. Modified Peptide YY Molecule Attenuates the Activity of NPY/AgRP Neurons and Reduces Food Intake in Male Mice.
Jones ES; Nunn N; Chambers AP; Østergaard S; Wulff BS; Luckman SM
Endocrinology; 2019 Nov; 160(11):2737-2747. PubMed ID: 31074796
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine.
Balasubramaniam A; Tao Z; Zhai W; Stein M; Sheriff S; Chance WT; Fischer JE; Eden PE; Taylor JE; Liu CD; McFadden DW; Voisin T; Roze C; Laburthe M
J Med Chem; 2000 Sep; 43(18):3420-7. PubMed ID: 10978189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
